Jeffrey G. Lamothe

Insider Reports History

Entity
Individual
Location
2401 4 Th Avenue, Suite 1050, Seattle, WA
Signature
/s/ SoYoung Kwon, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey G. Lamothe:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aptevo Therapeutics Inc. EVP, COO Restricted Stock Unit 3.67K Mar 3, 2024 Direct
Aptevo Therapeutics Inc. EVP, COO Common Stock 1.17K Aug 8, 2024 Direct
Aptevo Therapeutics Inc. EVP, COO Restricted Stock Unit 0 Aug 8, 2024 Direct

Insider Reports Filed by Jeffrey G. Lamothe

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APVO Aptevo Therapeutics Inc. Aug 8, 2024 4 $0 4 Aug 9, 2024 EVP, COO
APVO Aptevo Therapeutics Inc. Jul 17, 2024 1 $0 4 Jul 19, 2024 EVP, COO
APVO Aptevo Therapeutics Inc. Mar 2, 2024 4 $0 4 Mar 5, 2024 EVP, COO
APVO Aptevo Therapeutics Inc. Jan 28, 2024 2 $0 4 Jan 30, 2024 EVP, COO
APVO Aptevo Therapeutics Inc. Aug 8, 2023 4 $0 4 Aug 10, 2023 EVP, COO
APVO Aptevo Therapeutics Inc. Mar 3, 2023 4 $0 4 Mar 7, 2023 EVP, COO
APVO Aptevo Therapeutics Inc. Jan 29, 2023 2 $0 4 Jan 30, 2023 CFO
APVO Aptevo Therapeutics Inc. Aug 9, 2022 3 $0 4 Aug 10, 2022 CFO
APVO Aptevo Therapeutics Inc. Jun 7, 2022 1 $0 4 Jun 7, 2022 CFO
APVO Aptevo Therapeutics Inc. Mar 4, 2022 1 $0 4 Mar 4, 2022 CFO
APVO Aptevo Therapeutics Inc. Jan 29, 2022 2 $0 4 Feb 1, 2022 SVP and CFO